We have an amazing team of 4 inpatient, 2 OPAT, 1 peds, and 1 HIV pharmacists (and more) to work with!
We have an amazing team of 4 inpatient, 2 OPAT, 1 peds, and 1 HIV pharmacists (and more) to work with!
🆕🔥DOTS RCT
Among participants with complicated S aureus bacteremia who achieved blood culture clearance, dalbavancin was not superior to standard therapy for achieving a more desirable outcome at day 70 #idsky
jamanetwork.com/journals/jam...
🆕🔥DOTS RCT
Among participants with complicated S aureus bacteremia who achieved blood culture clearance, dalbavancin was not superior to standard therapy for achieving a more desirable outcome at day 70 #idsky
jamanetwork.com/journals/jam...
New PK/PD data says: it’s not just about higher doses—MIC matters.
2g q6h works only if MIC <=0.5 mg/L
For MIC:1-2 mg/L, continuous infusion (10–12g/day) may be needed to hit PD targets #idsky
journals.asm.org/doi/10.1128/...
New PK/PD data says: it’s not just about higher doses—MIC matters.
2g q6h works only if MIC <=0.5 mg/L
For MIC:1-2 mg/L, continuous infusion (10–12g/day) may be needed to hit PD targets #idsky
journals.asm.org/doi/10.1128/...
Huge congrats to Drs. Joshua Davis, Steven Tong, & the global team who made this ambitious trial happen. #IDSky blogs.jwatch.org/hiv-id-obser...
Huge congrats to Drs. Joshua Davis, Steven Tong, & the global team who made this ambitious trial happen. #IDSky blogs.jwatch.org/hiv-id-obser...
HUGE shoutout to data archivists- this work is important 👏🙌🏻
archive.org/details/2025...
HUGE shoutout to data archivists- this work is important 👏🙌🏻
archive.org/details/2025...
📲 www.idstewardship.com/year-review-...
#IDsky with @absteward.bsky.social
📲 www.idstewardship.com/year-review-...
#IDsky with @absteward.bsky.social